TY - JOUR
T1 - Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction
AU - Tsutsumi, Takaki
AU - Ide, Tomomi
AU - Yamato, Mayumi
AU - Kudou, Wataru
AU - Andou, Makoto
AU - Hirooka, Yoshitaka
AU - Utsumi, Hideo
AU - Tsutsui, Hiroyuki
AU - Sunagawa, Kenji
N1 - Funding Information:
We thank Dr Atsunori Kamiya (National Cardiovascular Centre Research Institute, Osaka, Japan) for technical advice and Ms Keiko Kurakazu for technical assistance. We appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University.
Funding Information:
This study was supported in part by grants from the Ministry of Education, Science and Culture (Nos 17790490 and 17790037), and from the Ministry of Health, Labor, and Welfare (Research Grant for Comprehensive Research in Aging and Health Labor and Welfare of Japan), Grant from Japan Cardiovascular Research Foundation, Uehara Memorial Foundation, and Mitsubishi Pharma Research Foundation. A part of this study was conducted in Kyushu University Station for Collaborative Research II.
PY - 2008/3
Y1 - 2008/3
N2 - Aims: Redox alteration plays a major role in the pathogenesis of heart failure (HF). Since vagal nerve stimulation (VNS) is known to improve survival and attenuate cardiac remodelling, we hypothesized that VNS may modulate the myocardial redox state. Methods and results: Using a chronic HF mouse model, we applied VNS for 15 min and measured myocardial redox status using in vivo electron spin resonance spectroscopy. Signal decay rate of the nitroxyl probe, an index of redox status, was enhanced in HF compared with sham (0.16 ± 0.01 vs. 0.13 ± 0.01 min-1, P < 0.05; n = 6), and VNS normalized this enhancement (0.13 ± 0.01 min-1, P < 0.05). Atropine sulphate abolished the VNS effects, indicating that the VNS modulates myocardial redox state via muscarinic receptors. Nω-Nitro-L- arginine methyl ester treatment and fixed-rate atrial pacing showed a trend to suppress the VNS effects, suggesting the involvement of nitric oxide-based signalling and myocardial oxygen consumption. Moreover, VNS decreased the myocardial norepinephrine (NE) level (0.25 ± 0.07 vs. 0.60 ± 0.12 ng/mL, P < 0.05; n = 6). Reactive oxygen species production from cultured cardiomyocytes was enhanced by β-adrenergic activation, which was partially antagonized by 10 μmol/L acetylcholine (ACh) (relative value compared with control: NE 3.7 ± 0.5, NE + ACh 2.5 ± 0.3, P < 0.05; n = 12). Conclusion: The present study suggests that VNS modulates the cardiac redox status and adrenergic drive, and thereby suppresses free radical generation in the failing heart.
AB - Aims: Redox alteration plays a major role in the pathogenesis of heart failure (HF). Since vagal nerve stimulation (VNS) is known to improve survival and attenuate cardiac remodelling, we hypothesized that VNS may modulate the myocardial redox state. Methods and results: Using a chronic HF mouse model, we applied VNS for 15 min and measured myocardial redox status using in vivo electron spin resonance spectroscopy. Signal decay rate of the nitroxyl probe, an index of redox status, was enhanced in HF compared with sham (0.16 ± 0.01 vs. 0.13 ± 0.01 min-1, P < 0.05; n = 6), and VNS normalized this enhancement (0.13 ± 0.01 min-1, P < 0.05). Atropine sulphate abolished the VNS effects, indicating that the VNS modulates myocardial redox state via muscarinic receptors. Nω-Nitro-L- arginine methyl ester treatment and fixed-rate atrial pacing showed a trend to suppress the VNS effects, suggesting the involvement of nitric oxide-based signalling and myocardial oxygen consumption. Moreover, VNS decreased the myocardial norepinephrine (NE) level (0.25 ± 0.07 vs. 0.60 ± 0.12 ng/mL, P < 0.05; n = 6). Reactive oxygen species production from cultured cardiomyocytes was enhanced by β-adrenergic activation, which was partially antagonized by 10 μmol/L acetylcholine (ACh) (relative value compared with control: NE 3.7 ± 0.5, NE + ACh 2.5 ± 0.3, P < 0.05; n = 12). Conclusion: The present study suggests that VNS modulates the cardiac redox status and adrenergic drive, and thereby suppresses free radical generation in the failing heart.
UR - http://www.scopus.com/inward/record.url?scp=39749170512&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39749170512&partnerID=8YFLogxK
U2 - 10.1093/cvr/cvm092
DO - 10.1093/cvr/cvm092
M3 - Article
C2 - 18065771
AN - SCOPUS:39749170512
SN - 0008-6363
VL - 77
SP - 713
EP - 721
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 4
ER -